Stobo, John D.· Traill, Thomas A.· Hellmann, David B.· Ladenson, Paul W.· Petty, Brent G. (1996). The Principles and Practice of Medicine (στα Αγγλικά). McGraw Hill Professional. σελ. 933. ISBN9780071383653. high abuse liability
«From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs». Drug Testing and Analysis6 (7–8): 614–32. 2014. doi:10.1002/dta.1620. PMID24678061.
Millan, M. J.; Brocco, M.; Gobert, A.; Joly, F.; Bervoets, K.; Rivet, J. -M.; Newman-Tancredi, A.; Audinot, V. και άλλοι. (December 1999). «Contrasting mechanisms of action and sensitivity to antipsychotics of phencyclidine versus amphetamine: importance of nucleus accumbens 5-HT sites for PCP-induced locomotion in the rat». European Journal of Neuroscience11 (12): 4419–4432. doi:10.1046/j.1460-9568.1999.00858.x. PMID10594669.
Noda, Y.; Nabeshima, T. (1 September 1998). «Neuronal mechanisms of phencyclidine-induced place aversion and preference in the conditioned place preference task». Methods and Findings in Experimental and Clinical Pharmacology20 (7): 607–611. doi:10.1358/mf.1998.20.7.485726. ISSN0379-0355. PMID9819806.
Murrie, Benjamin; Lappin, Julia; Large, Matthew; Sara, Grant (16 October 2019). «Transition of Substance-Induced, Brief, and Atypical Psychoses to Schizophrenia: A Systematic Review and Meta-analysis». Schizophrenia Bulletin46 (3): 505–516. doi:10.1093/schbul/sbz102. PMID31618428.
«Comparison of haloperidol and chlorpromazine in the treatment of phencyclidine psychosis». Journal of Clinical Pharmacology24 (4): 202–4. Apr 1984. doi:10.1002/j.1552-4604.1984.tb01831.x. PMID6725621.
«The efficacy of sodium channel blockers to prevent phencyclidine-induced cognitive dysfunction in the rat: potential for novel treatments for schizophrenia». The Journal of Pharmacology and Experimental Therapeutics338 (1): 100–13. Jul 2011. doi:10.1124/jpet.110.178475. PMID21487071.
«Dopamine D2High receptors stimulated by phencyclidines, lysergic acid diethylamide, salvinorin A, and modafinil». Synapse63 (8): 698–704. 2009. doi:10.1002/syn.20647. PMID19391150.
«Nicotinic receptors on hippocampal cultures can increase synaptic glutamate currents while decreasing the NMDA-receptor component». Neuropharmacology39 (13): 2756–69. Oct 2000. doi:10.1016/s0028-3908(00)00102-7. PMID11044745.
«Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics». Molecular Psychiatry10 (9): 877–83. Sep 2005. doi:10.1038/sj.mp.4001682. PMID15852061.
«Comparison of chlorpromazine, haloperidol and pimozide in the treatment of phencyclidine psychosis: DA-2 receptor specificity». Journal of Toxicology. Clinical Toxicology22 (6): 573–9. 1984. doi:10.3109/15563658408992586. PMID6535849.
Johnson, K M; Jones, S M (April 1990). «Neuropharmacology of Phencyclidine: Basic Mechanisms and Therapeutic Potential». Annual Review of Pharmacology and Toxicology30 (1): 707–750. doi:10.1146/annurev.pa.30.040190.003423. PMID2160793.
«Chronic phencyclidine administration induces schizophrenia-like changes in N-acetylaspartate and N-acetylaspartylglutamate in rat brain». Schizophrenia Research73 (2–3): 147–52. Mar 2005. doi:10.1016/j.schres.2004.02.003. PMID15653257.
Bush, DM (2013). «Emergency Department Visits Involving Phencyclidine (PCP)». In: The CBHSQ Report. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2013–. PMID27656747. «PCP can lead to hostile behavior that may result in episodes of extreme violence».
«From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs». Drug Testing and Analysis6 (7–8): 614–32. 2014. doi:10.1002/dta.1620. PMID24678061.
Millan, M. J.; Brocco, M.; Gobert, A.; Joly, F.; Bervoets, K.; Rivet, J. -M.; Newman-Tancredi, A.; Audinot, V. και άλλοι. (December 1999). «Contrasting mechanisms of action and sensitivity to antipsychotics of phencyclidine versus amphetamine: importance of nucleus accumbens 5-HT sites for PCP-induced locomotion in the rat». European Journal of Neuroscience11 (12): 4419–4432. doi:10.1046/j.1460-9568.1999.00858.x. PMID10594669.
Noda, Y.; Nabeshima, T. (1 September 1998). «Neuronal mechanisms of phencyclidine-induced place aversion and preference in the conditioned place preference task». Methods and Findings in Experimental and Clinical Pharmacology20 (7): 607–611. doi:10.1358/mf.1998.20.7.485726. ISSN0379-0355. PMID9819806.
Murrie, Benjamin; Lappin, Julia; Large, Matthew; Sara, Grant (16 October 2019). «Transition of Substance-Induced, Brief, and Atypical Psychoses to Schizophrenia: A Systematic Review and Meta-analysis». Schizophrenia Bulletin46 (3): 505–516. doi:10.1093/schbul/sbz102. PMID31618428.
«Comparison of haloperidol and chlorpromazine in the treatment of phencyclidine psychosis». Journal of Clinical Pharmacology24 (4): 202–4. Apr 1984. doi:10.1002/j.1552-4604.1984.tb01831.x. PMID6725621.
«The efficacy of sodium channel blockers to prevent phencyclidine-induced cognitive dysfunction in the rat: potential for novel treatments for schizophrenia». The Journal of Pharmacology and Experimental Therapeutics338 (1): 100–13. Jul 2011. doi:10.1124/jpet.110.178475. PMID21487071.
«Dopamine D2High receptors stimulated by phencyclidines, lysergic acid diethylamide, salvinorin A, and modafinil». Synapse63 (8): 698–704. 2009. doi:10.1002/syn.20647. PMID19391150.
«Site of action of phencyclidine. IV. Interaction of phencyclidine and its analogues on ionic channels of the electrically excitable membrane and nicotinic receptor: implications for behavioral effects». Molecular Pharmacology21 (3): 637–47. May 1982. PMID6287200.
«Novel analogues of ketamine and phencyclidine as NMDA receptor antagonists». Bioorganic & Medicinal Chemistry Letters21 (7): 2059–63. Apr 2011. doi:10.1016/j.bmcl.2011.02.009. PMID21334205.
«Nicotinic receptors on hippocampal cultures can increase synaptic glutamate currents while decreasing the NMDA-receptor component». Neuropharmacology39 (13): 2756–69. Oct 2000. doi:10.1016/s0028-3908(00)00102-7. PMID11044745.
«Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics». Molecular Psychiatry10 (9): 877–83. Sep 2005. doi:10.1038/sj.mp.4001682. PMID15852061.
«Comparison of chlorpromazine, haloperidol and pimozide in the treatment of phencyclidine psychosis: DA-2 receptor specificity». Journal of Toxicology. Clinical Toxicology22 (6): 573–9. 1984. doi:10.3109/15563658408992586. PMID6535849.
«The psychotomimetic drug phencyclidine labels two high affinity binding sites in guinea pig brain: evidence for N-methyl-D-aspartate-coupled and dopamine reuptake carrier-associated phencyclidine binding sites». Molecular Pharmacology36 (6): 887–96. Dec 1989. PMID2557536.
Johnson, K M; Jones, S M (April 1990). «Neuropharmacology of Phencyclidine: Basic Mechanisms and Therapeutic Potential». Annual Review of Pharmacology and Toxicology30 (1): 707–750. doi:10.1146/annurev.pa.30.040190.003423. PMID2160793.
«Chronic phencyclidine administration induces schizophrenia-like changes in N-acetylaspartate and N-acetylaspartylglutamate in rat brain». Schizophrenia Research73 (2–3): 147–52. Mar 2005. doi:10.1016/j.schres.2004.02.003. PMID15653257.
Noda, Y.; Nabeshima, T. (1 September 1998). «Neuronal mechanisms of phencyclidine-induced place aversion and preference in the conditioned place preference task». Methods and Findings in Experimental and Clinical Pharmacology20 (7): 607–611. doi:10.1358/mf.1998.20.7.485726. ISSN0379-0355. PMID9819806.